Organon (OGN) Other Non Operating Income (2020 - 2026)

Organon (OGN) posted quarterly Other Non Operating Income of $96.0 million for Q1 2026, up 2300.0% year-over-year from $4.0 million in Q1 2025, and up 243.28% on a QoQ basis from -$67.0 million in Q4 2025.

Organon (OGN) Other Non Operating Income (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Other Non Operating Income for 7 consecutive years, with $96.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 2300.0% year-over-year to $96.0 million; the TTM figure through Mar 2026 stood at $60.0 million (up 957.14% YoY), while the FY2025 annual figure was -$14.0 million, up 33.33% from the prior year.
  • Other Non Operating Income came in at $96.0 million for Q1 2026 at Organon, up from -$67.0 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $96.0 million in Q1 2026, with the low at -$67.0 million in Q4 2025.
  • Average Other Non Operating Income over 5 years is $1.6 million, with a median of -$3.0 million recorded in 2022.
  • Across the five-year window, Other Non Operating Income slumped 1700.0% in 2022 and soared 2300.0% in 2026, its largest moves.
  • Year by year, Other Non Operating Income stood at -$32.0 million in 2022, then jumped by 131.25% to $10.0 million in 2023, then plunged by 220.0% to -$12.0 million in 2024, then slumped by 458.33% to -$67.0 million in 2025, then surged by 243.28% to $96.0 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $96.0 million, -$67.0 million, and $30.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 96.00 Mn
Dec 31, 2025 -67.00 Mn
Sep 30, 2025 30.00 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 4.00 Mn
Dec 31, 2024 -12.00 Mn
Jun 30, 2024 1.00 Mn
Mar 31, 2024 -6.00 Mn
Dec 31, 2023 10.00 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 -6.00 Mn
Dec 31, 2022 -32.00 Mn
Sep 30, 2022 -4.00 Mn
Jun 30, 2022 21.00 Mn
Mar 31, 2022 -4.00 Mn
Dec 31, 2021 2.00 Mn
Sep 30, 2021 -1.00 Mn
Jun 30, 2021 -20.00 Mn
Mar 31, 2021 2.00 Mn